Archive for the ‘Lyme’ Category

Paralyzed by Lyme, They Were Helped With Combo Treatments

https://www.lymedisease.org/remission-from-lyme-paralysis/

Paralyzed by Lyme, they were helped with combo treatments

By Lonnie Marcum

July 19, 2023

A new study from France looks at the use of combination antibiotics and anti-parasitic treatments in patients with limb paralysis as a result of tick-borne infections, including Lyme disease.

Approximately 70% of the patients in this study showed complete remission of symptoms after long-term treatment—a statistic that lines up with the MyLymeData treatment study.

The paper entitled, Complete Remission in Paralytic Late Tick-Borne Neurological Disease Comprising Mixed Involvement of Borrelia, Babesia, Anaplasma, and Bartonella: Use of Long-Term Treatments with Antibiotics and Antiparasitics in a Series of 10 Cases was published in Antibiotics.

The inclusion criteria for this study required a score of 4 or more on the Kurtzke EDSS disability scale; positive blood tests for one or more tick-borne pathogen (including Borrelia burgdorferi, Babesia, Anaplasma or Bartonella); and chronic general symptoms including fatigue, pain, and cognitive deficits lasting six or more months.

The Extended Disability Status Scale (EDSS) is a tool commonly used to quantify the level of disability in patients with multiple sclerosis. The EDSS grades six bodily functions, including visual, brain, bowel/bladder and sensory functions, as well as the patients’ ability to walk and take care of themselves.

All 10 of the patients that qualified for this study were severely disabled with partial or complete paralysis in at least one limb. Five of the 10 required a wheelchair for mobility, and four required assistive devices like walking sticks to get around.

Complete remission for 7 out of 10

Following extended treatment, seven out of 10 patients (70%) showed complete remission of symptoms. Among the nine patients with positive Borrelia serology (along with co-infections), 77% obtained complete remission.

The treatment administered varied according to the patient’s infection profile. The majority of the patients received repeated oral regimens of azithromycin-doxycycline and azithromycin-doxycycline-rifampin plus a minimum of three 35-day cycles of IV ceftriaxone. The eight patients co-infected with Babesia (a parasite) were also administered anti-parasitic cycles of atovaquone–azithromycin. The mean duration of treatment was 20 months +/- 6 months. (Trouillas 2023)

Historically, patients with late-stage Lyme disease have poor outcomes to single regimens of 10-day IV ceftriaxone. (I’ve previously written about brain inflammation, and small fiber neuropathy found in patients with continuing symptoms after short-term treatment for Lyme disease.)

And we have decades of strong evidence that under-treatment with single antibiotics is consistent with persistent infection in animal studies. (Embers 2012)

Two weeks isn’t enough

As far back as 1990, Dr. Allen Steere co-authored a paper on patients with persistent late-stage neurological Lyme disease.

In this paper Dr. Steere and his co-authors state:

Months to years after the initial infection with B. burgdorferi, patients with Lyme disease may have chronic encephalopathy, polyneuropathy, or less commonly, leukoencephalitis. These chronic neurologic abnormalities usually improve with antibiotic therapy.
…
Six months after a two-week course of intravenous ceftriaxone (2 g daily), 17 patients (63 percent) had improvement, 6 (22 percent) had improvement but then relapsed, and 4 (15 percent) had no change in their condition.
…
Six months after treatment, more than one third of the patients either had relapsed or were no better. In addition, more than half had previously received antibiotic therapy thought to be appropriate for their stage of disease and still had progression of the illness. The likely reason for relapse is failure to eradicate the spirochete completely with a two-week course of intravenous ceftriaxone therapy. (Logigian 1990)

MyLymeData

In fact, the MyLymeData study validates that longer antibiotic treatment durations are associated with moderate to a very great deal of improvement. (Johnson 2020)

MyLymeData is currently the largest observational study of patients using real-world data to analyze the response to treatment of chronic Lyme disease patients. The majority of patients (57%) reported treatment durations of four or more months,

The results of this new French study demonstrate the importance of clinicians being able to continue treatment until a patient’s symptoms have resolved. It is clear, at least in this study, that the presence of co-infections greatly compounds one’s disease progress and treatment options.

LymeSci is written by Lonnie Marcum, a Licensed Physical Therapist and mother of a daughter with Lyme. She served two terms on a subcommittee of the federal Tick-Borne Disease Working Group. Follow her on Twitter: @LonnieRhea  Email her at: lmarcum@lymedisease.org.

References

Embers ME, Barthold SW, Borda JT, Bowers L, Doyle L, Hodzic E, et al. Persistence of Borrelia burgdorferi in Rhesus Macaques following Antibiotic Treatment of Disseminated Infection. PLoS ONE. 2012;7(1):e29914. Available at: http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0029914.

 Johnson, L.; Shapiro, M.; Stricker, R.B.; Vendrow, J.; Haddock, J.; Needell, D. Antibiotic Treatment Response in Chronic Lyme Disease: Why Do Some Patients Improve While Others Do Not? Healthcare 2020, 8, 383. https://www.mdpi.com/2227-9032/8/4/383

Logigian EL, Kaplan RF, Steere AC. Chronic neurologic manifestations of Lyme disease. N Engl J Med. 1990 Nov 22;323(21):1438-44. doi: 10.1056/NEJM199011223232102. PMID: 2172819.

Trouillas P, Franck M. Complete Remission in Paralytic Late Tick-Borne Neurological Disease Comprising Mixed Involvement of Borrelia, Babesia, Anaplasma, and Bartonella: Use of Long-Term Treatments with Antibiotics and Antiparasitics in a Series of 10 Cases. Antibiotics. 2023; 12(6):1021. https://doi.org/10.3390/antibiotics12061021

_________________

For more:

Category:

Anaplasmosis, Babesia, Bartonella, Lyme, research, Treatment

Lyme Disease & the Pursuit of a Clinical Cure

https://www.frontiersin.org/articles/10.3389/fmed.2023.1183344/full

REVIEW article

Front. Med., 24 May 2023
Sec. Infectious Diseases: Pathogenesis and Therapy
Volume 10 – 2023 | https://doi.org/10.3389/fmed.2023.1183344

Lyme disease and the pursuit of a clinical cure

Heather Adkison and Monica E. Embers*
  • Division of Immunology, Tulane National Primate Research Center, Tulane University Health Sciences, Covington, LA, United States

Lyme disease, caused by the spirochete Borrelia burgdorferi, is the most common vector-borne illness in the United States. Many aspects of the disease are still topics of controversy within the scientific and medical communities. One particular point of debate is the etiology behind antibiotic treatment failure of a significant portion (10–30%) of Lyme disease patients. The condition in which patients with Lyme disease continue to experience a variety of symptoms months to years after the recommended antibiotic treatment is most recently referred to in the literature as post treatment Lyme disease syndrome (PTLDS) or just simply post treatment Lyme disease (PTLD). The most commonly proposed mechanisms behind treatment failure include host autoimmune responses, long-term sequelae from the initial Borrelia infection, and persistence of the spirochete. The aims of this review will focus on the in vitro, in vivo, and clinical evidence that either validates or challenges these mechanisms, particularly with regard to the role of the immune response in disease and resolution of the infection. Next generation treatments and research into identifying biomarkers to predict treatment responses and outcomes for Lyme disease patients are also discussed. It is essential that definitions and guidelines for Lyme disease evolve with the research to translate diagnostic and therapeutic advances to patient care.

_________________

Translation:  TIME FOR CHANGE!

Thankfully the study authors point out the following:
  • Without intervention, Bb establishes a persistent/chronic infection in both its reservoir and non-reservoir hosts.  
  • Controversy regarding chronic infection revolves around whether Bb can persist after antibiotics and whether they are capable of causing the symptoms patients experience.
  • There are many bacterial species associated with persistent infections in humans including: Mycobacterium tuberculosis, Pseudomonas aeruginosa, Escherichia coli, Staphylococcus aureus, and B. burgdorferi (109).
  • Bacterial tolerance is different from resistance in that bacteria are not actively growing in the presence of the antibiotic and there is no heritable genetic change in the persistent bacteria’s genome (110, 111).
  • The stress response and other mechanisms allow bacteria, including Borrelia, to survive lethal conditions such as limited nutrients, extreme pH levels, and the presence of certain antibiotics.
  • Drug-induced bacterial persisters show a biphasic killing curve and the regrown persister cells have the same minimum inhibitory concentration (MIC) to the administered antibiotic as the original population but a higher minimum bactericidal concentration (MBC) (112).
  • Several independent studies have demonstrated that Bb can form drug-tolerant persister cell in vitro.
  • In vivo studies of Bb antibiotic persistence often use different parameters that can make comparisons between two or more studies difficult.
  • It is likely that lack of consensus of definitions and diagnosis lead to the treatment controversy.
  • Despite treatment controversy, a biostatistical review of the literature found that retreatment of LD with antibiotics may be beneficial in certain cases (163).
  • Since research for PTLD revolves around autoimmunity, immune-mediated factors, and/or persistent infection, most drugs fit into one of three categories: immune therapies, pathogen specific inhibitors, or antibiotics.
  • Studies screening drug libraries have revealed:
    • disulfiram has demonstrated borreliacidal activity both in vitro and in vivo (174–176)
    • vancomycin may have efficacy against stationary Bb based upon cultures and evaluation in SCID mice (177)
    • hygromycin A has shown efficacy against Bb, without disturbing the gut microbiome like so many broad-spectrum antibiotics, in vitro and in an in vivo mouse assay, but it’s use in preventing persistent infections was not determined (178)
    • drug combinations such as daptomycin or artemisinin, cefoperazone, and doxycycline as well as the combination sulfachlorpyridazine, daptomycin, and doxycycline have shown evidence of in vitro activity against Bb persisters and round bodied forms (117, 172). Azlocillin and cefotaxime are effective in in vitro killing against Bb persisters induced by doxycycline, which appear to be more tolerant to other antibiotics (179).
    • daptomycin or daunomycin, doxycycline, and cefuroxime have had success in sterilizing in vitro Bb biofilm-like microcolonies (180, 181).
    • dapsone, used in treatment of leprosy, has had success when combined with other antibiotics in killing biofilm-like Bb (182), and dapsone has had positive effects in a small PTLD and co-infection clinical study (183).
    • oregano, cinnamon bark, clove, and various flowers, grasses, and berries, as well as natural compounds such as those found in bee venom and its component melittin have demonstrated potential in vitro growth inhibition against Bb and its various forms (184–188) but need further research to determine the safety and efficacy of, and the composition and activity of the exact compounds found.
  • Curative treatment during early LD stages is a key to solving the current PTLD public health problem.
  • It is likely that more than one mechanism is involved in antibiotic treatment failure that leads to PTLD.
  • The current treatment guidelines are dependent upon the immune system’s ability to clear persistent spirochetes and conditional to the surviving spirochetes being non-viable and not enough to sustain a prolonged immune response.
  • In order to make PTLD a thing of the past, personalized medicine is required as well as the need to evolve and progress with scientific discoveries and innovations.  

Category:

Herbs, Lyme, research, Treatment

Yet Another Magazine Uses Name Calling To Belittle Lyme Patients

https://www.change.org/p/the-us-senate-calling-for-a-congressional-investigation-of-the-cdc-idsa-and-aldf/u/31708332

Insider article: A woman is trying out a 4-dose Lyme disease vaccine

Carl Tuttle

Hudson, NH, United States

JUN 28, 2023 — 

Please read the following complaint letter sent to the Insider regarding inaccurate information relating to Lyme vaccines.

———- Original Message ———-
From: CARL TUTTLE <runagain@comcast.net>
To: “corrections@insider.com” <corrections@insider.com>
Cc: “hbrueck@businessinsider.com” <hbrueck@businessinsider.com>, “jhood@insider.com” <jhood@insider.com>, “hbeckler@insider.com” <hbeckler@insider.com>, “rzisser@insider.com” <rzisser@insider.com>, “cpreti@insider.com” <cpreti@insider.com>, “pdifiore@insider.com” <pdifiore@insider.com>, “information@axelspringer.de” <information@axelspringer.de>
Date: 06/28/2023 11:53 AM EDT
Subject: A woman is trying out a 4-dose Lyme disease vaccine as we approach the worst summer for ticks yet

Insider

A woman is trying out a 4-dose Lyme disease vaccine as we approach the worst summer for ticks yet
https://www.insider.com/lyme-vaccine-for-people-being-tested-across-us-europe-pfizer-2023-6

By Hilary Brueck  Jun 27, 2023

“Although studies showed it [LYMErix] was about 75% effective at stopping Lyme disease, it received a lukewarm public reception and was the subject of conspiracy-theory lawsuits, driving down sales and leading it to be quickly taken off the market.”

Insider
1 Liberty Plz Fl 8,
New York, New York, 10006

To: the management team at Insider,

I would like to register a complaint regarding the statement highlighted above. The following link will take you to the Vaccines and Related Biological Products Advisory Committee’s January 31, 2001 meeting:
Vaccines and Related Biological Products Advisory Committee Meeting
Excerpt:

“The people who have contacted us were, prior to vaccination with LYMErix, healthy, active and energetic. Indeed, the very reason they sought the LYMErix vaccine was their desire to preserve their healthy, active lifestyle. However, what they experienced was a dramatic degradation of their health and quality of life. As will be described below, these previously healthy individuals are now afflicted with painful, at times debilitating arthritic symptoms, including joint pain and swelling, as well as extremely severe Lyme-disease-like symptoms which have persisted to this day.” 

Question: Does that sound like a conspiracy-theory?

Additional concerns:

There were neurological complications with the previous “OspA-Based” Lyme vaccine (LYMErix) as published in the International Journal of Risk & Safety in Medicine. Reports of cerebral ischemia, transient Ischemic attacks, demyelinating events, optic neuritis, transverse myelitis, and non-specific demyelinating conditions are evaluated in this paper. To my knowledge, there were no studies to determine why LYMErix caused these serious complications.

Neurological complications of vaccination with outer surface protein A (OspA)
https://content.iospress.com/articles/international-journal-of-risk-and-safety-in-medicine/jrs527

And we are to believe Pfizer will bring a “safe and effective” product to market? A company that paid the highest fine for health care fraud:

Justice Department Announces Largest Health Care Fraud Settlement in Its History
 
Pfizer to Pay $2.3 Billion for Fraudulent Marketing (Wednesday, September 2, 2009)
https://www.justice.gov/opa/pr/justice-department-announces-largest-health-care-fraud-settlement-its-history

A chronic relapsing seronegative disease does not fit the vaccine model so deny the chronically infected and your patents for vaccines and diagnostic technology continue to reap patent royalties as evidence of persistent infection (following the one-size-fits-all IDSA mandated treatment protocol) must be concealed/ignored at all costs.

In the interest of time I have shortened the evidence to five points below with most reference links taken from the NH COMMISSION TO STUDY TESTING FOR LYME AND OTHER TICK-BORNE DISEASES of which I was a member appointed by Governor Chris Sununu:

Barbara Johnson of the CDC put Advanced Laboratory Services out of business after the lab was reporting 80% positive culture results. If contamination was an issue as Johnson claimed,[i] why didn’t the CDC work with Advanced Laboratory Services to correct the problem? Culture is the gold standard for definitive diagnosis of bacterial and fungal infections worldwide but when it threatens the existing paradigm suddenly it becomes “not particularly useful.” Johnson by the way filed her own patent  [ii] a year earlier for the detection, diagnosis and/or treatment of Lyme disease.

Dr. Sin Lee had been working with the CDC on a project to develop proficiency testing for his DNA sequencing-based tests for Lyme Borreliosis (Approved by the New York Dept. of Health) When Dr. Lee reported a case of chronic [iii] Lyme through Sanger sequencing suddenly all communication stopped. A positive DNA test is irrefutable evidence of active infection.

The CDC refuses to recognize the mountain of publications identifying persistent infection after extensive antibiotic treatment. A chronic relapsing seronegative disease should have set off a red flag but its misclassification as a simple “nuisance disease” has left hundreds of thousands if not millions worldwide in a debilitated state.

The CDC refuses to recognize the disabling stage of Lyme disease as reported by the Lyme patient population worldwide because it contradicts the CDC 30yr Official Narrative; “Lyme is hard to catch and easily treated with 2-4wks of antibiotics” Social Security disability compensation is denied leaving patients to fend for themselves.

Serology (Western blot) was manipulated to facilitate vaccine development. The two most significant bands, 31 (Outer surface protein A) and band 34 (Outer surface protein B) of the spirochete were removed as those who were vaccinated would test positive. Humans do not produce antibodies to Lyme disease for 4-6 weeks after a tick bite so serology has always been the wrong diagnostic tool but absolutely essential to deceptively prove vaccine efficacy.

Patent royalties and pharmaceutical profits [iv] over lifesaving care.

Unimaginable pain and suffering for the sake of a vaccine while our public health officials ignore the evidence that we are dealing with an antibiotic resistant/tolerant superbug.

Questions: Where is the outrage? Will any of these facts find their way into a revised article at the Insider or is the conspiracy-theory statement final? Who coached Hilary Brueck in the writing of her article?

A response to this complaint is requested.

Carl Tuttle
Hudson, NH

To TBDWG: “The CDC has propagated a false Lyme disease narrative”
https://www.lymedisease.org/tuttle-tbdwg-false-narrative/

Re: Lyme borreliosis: diagnosis and management (Published letter to the editor of the BMJ)
https://www.bmj.com/content/369/bmj.m1041/rr-1

Additional References

[i] Assessment of New Culture Method for Detection of Borrelia Species from Serum of Lyme Disease Patients

Barbara J. B. Johnson, Mark A. Pilgard, and Theresa M. Russell
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3957795/

[ii] COMPOSITIONS AND METHODS RELATING TO LYME DISEASE
https://patents.google.com/patent/WO2013110026A1/en?oq=ininventor:%22Barbara+J.B.+JOHNSON%22

[iii] Lyme disease caused by Borrelia burgdorferi with two homeologous 16S rRNA genes: a case report

Johnson Patent
https://pubmed.ncbi.nlm.nih.gov/27186082/

[iv] Valneva Receives FDA Fast Track Designation for its Lyme Disease Vaccine Candidate VLA15
https://valneva.com/wp-content/uploads/2019/06/2017_07_24_VLA_Lyme_FDA_Fast_track_PR_EN.pdf

____________________

**Comment**

It is clear Brueck was coached from one of many in the Lyme Cabal.  Proof the Lyme narrative is being controlled:

  • Cabalist Gary Wormser has developed diagnostics for Pfizer’s Lyme “vaccine” trial.  The man continues to use taxpayer money to propagate the ongoing Lyme narrative.
  • Cabalist Dr. Mark Klempner calls LYMErix’s removal a “tragedy.” Please know the backstory on Klempner, which includes a history with biological weapons as both director and investigator of a bioweapons lab, accusations of research fraud, and his single-handedly convincing mainstream medicine that extended treatment won’t help Lyme/MSIDS patients. The infamous “Klempner” trial has ruled Lyme-land for over 20 years.  Klempner was also the trial administrator of the Connaught OspA Lyme vaccine in the 1990s, and is quite aware of the adverse effects of injecting OspA into people, yet despite all of this, he  was an author of the 2006 IDSA Lyme Treatment “Guidelines” that were the subject of an investigation by Senator Richard Blumenthal which exposed undisclosed financial conflicts in many of the panelists as well as the fact they simply ignored alternative medical opinion (which is happening again with COVID). Those guidelines relied heavily on his 2001 “retreatment” study in which most of the participants had not been treated in the first place.  He claims his new shot isn’t a “vaccine;” however, according to this,  OspA is still in it. Here’s what Dr. Stricker has to say about OspA: 

Another Lyme OspA Vaccine Whitewash

The meta-analysis by Zhao and colleagues comes to the conclusion that “the OspA vaccine against Lyme disease is safe and its immunogenicity and efficacy have been verified.” The authors arrive at this sunny conclusion by excluding 99.6% of published articles that demonstrate potential problems with the OspA vaccine. Furthermore, the authors ignore peer-reviewed studies, FDA regulatory meetings and legal proceedings that point to major problems with OspA vaccine safety (1-3). This whitewash bodes ill for future Lyme vaccine candidates because it fosters disregard for vaccine safety among Lyme vaccine manufacturers and mistrust among potential Lyme vaccinees.

  • Cabalist Sam Telford teaches biosecurity, specializes in the bioweapon Tularemia, and was the director of a bio-level 3 lab in Groton, Massachusetts that works on dangerous, tickborne diseases on the government’s select agent list.  He’s funded by the NIH and the military-industrial complex but dismisses all concerns of biowarfare research and spends his time bad-mouthing doctors who dare to defy the narrative. He laments and blames a rotavirus vaccine for children that was demonstrated to actually do harm added to the growing anti-vaccine sentiment around the same time of Lymerix, making us question if the man has a heart in his body at all or is merely stuffed with straw.
  • Cabalist Linden Hu, recruited by Klempner, is a professor of Microbiology and Basic Science at Tufts Graduate School of Biomedical Sciences and is fixated on the ever lucrative vaccine-infused mouse food which contains a virus what he insists is safe.  Thankfully the U.S. Dept. of Agriculture is leery.  He has also proposed putting an antibiotic into mouse food at bait stations. The science it’s all based on was done more than a decade ago. This project was also stalled due to fears of antibiotic resistance.  Given the appropriate title of the “crazy man” of Lyme disease, he is leading NIH funded studies to investigate feeding live ticks on people as a diagnostic test and releasing genetically altered viruses to prevent disease in the animals in the wild.  His laboratory works with leading pharmaceutical companies in the development of vaccines and other approaches to prevent human Lyme disease.  Hu and Telford just received nearly 4 MILLION from the NIH to study a more narrow-spectrum antibiotic.
I’m having flash-backs of childhood cartoons of mad scientists that want to rule the world.

Category:

Activism, Lyme, vaccines

CDC Altering Death Certificates Again

https://brownstone.org/articles/the-great-covid-laundering-scheme/

The Great Covid Laundering Scheme

BY    JULY 12, 2023 

The CDC seems to have been systematically swapping in Covid as the Underlying Cause of Death on death certificates listing a different condition as the UCoD.

To briefly recap what we’ve covered in previous articles, the CDC applies medical diagnostic codes from the ICD-10 database for all conditions listed as a CoD on death certificates.

The thesis explores how the CDC has been systematically misclassifying covid as the UCoD on death certificates that clearly list a different condition as the Underlying Cause of Death, or where covid was obviously not the UCoD even if it was technically listed in the position of the UCoD by the coroner or ME who filled out the death certificate. The CDC does this by entering the ICD code for covid – U07.1 – as the UCoD even though the death certificate itself lists a different condition as the UCoD.

To be clear, this isn’t meant to capture coroners adding covid as a CoD where covid clearly was clinically irrelevant. Rather, what I am highlighting is a subset of “covid” deaths where the CDC swapped in covid as the UCoD even though it wasn’t documented as the UCoD on the death certificate by the coroner/ME.

In other words, potentially an enterprise of systemic out-and-out fraud by the CDC to falsely portray deaths that at best covid ‘helped’ hasten the demise of the decedent as deaths where the death was primarily instigated by covid.   (See link for article)

https://brownstone.org/articles/cdc-altered-death-certificates/

CDC Altered Minnesota Death Certificates that List a Covid Vaccine as a Cause of Death

BY    JULY 3, 2023 

Someone (who needs to remain anonymous) was able to obtain the death certificates from Minnesota for all deaths that occurred from 2015 to the present, which presented the opportunity to see if the CDC is being entirely honest about the US death data. Unsurprisingly, the CDC is not.

As we shall document, the CDC is concealing references to a covid vaccine on Minnesota death certificates (that are exceedingly rare to begin with because of widespread medical establishment denialism of vaccine adverse side effects). In almost every death certificate that identifies a covid vaccine as a cause of death, the CDC committed data fraud by not assigning the ICD 10 code for vaccine side effects to the causes of death listed on the death certificate.

Background

When someone dies, there is a death certificate that is filled out for official/legal purposes. Death certificates contain a lot of information (some states include more than others), including the causes of death (CoD).

Causes of death refer to the medical conditions that ultimately played some role in the demise of the decedent. To qualify as a CoD, a condition only needs to contribute to the medical decline of the decedent in some way, but doesn’t have to be directly responsible for whatever ultimately killed the person. If someone had high blood pressure, and subsequently suffered a heart attack that led to cardiac arrest which killed them, all three conditions qualify as CoD. On the other hand, this unfortunate fellow’s ingrown toenail is not a cause of death, because it in no way contributed to their demise.

(See link for article)

____________________

**Comment**

  • It’s the CDC’s job to assign ICD (International Classification of Diseases) 10 codes via  a secret algorithm, with only a tiny percentage adjudicated by CDC staff.
  • While there are codes for literally every random bizarre thing you can think of, there are only TWO codes given for COVID shot side effects.
  • The article gives 7 examples of death certificates from Minnesota of those who died within hours to days that identify the COVID shot as a cause of death but the CDC fraudulently omitted the ICD 10 code.
  • It is noteworthy that the average age of the decedents is 80, and 7/9 died before May 2021, a time of maximum prejudice against acknowledging the shots can trigger lethal pathologies.  Young people “dying suddenly” sticks out but the death of the old and frail receives much less attention and is simply blamed on age.

There are many inherent problems with CDC death statistics:

  • hospitals were paid to count deaths as COVID even when there were confounding issues and COVID wasn’t the direct cause of death.
  • infant deaths due to vaccines are never listed on death certificates but are listed as SIDS due to the lack of an ICD code,  Without a code, it simply doesn’t exist and therefore can not be tracked or numbered.
  • has been described as a “circular mortality rate generating system” that regurgitates the same causes of death over and over due to the fact doctors provide the simplest natural cause as they know it will quickly pass the approval of the local registrar’s office. This means any hope of capturing deaths caused by or complicated by a vaccine or drug is lost and enables deaths caused by Big Pharma to remain unnoticed and uncounted.
  • similarly to fraudulent testing which is controlled and patented by the CDC, the agency’s domination of coding also allows them to control the narrative.

Category:

Lyme, vaccines, Viruses

Study Finds Classical Lyme Testing Does Not Aid in Diagnosis of Persistent Symptoms

https://www.mdpi.com/2075-1729/13/5/1134

Classical Borrelia Serology Does Not Aid in the Diagnosis of Persistent Symptoms Attributed to Lyme Borreliosis: A Retrospective Cohort Study

by 1,2,*, 2,3, 2,3, 2,3, 3 and 2,3
*Author to whom correspondence should be addressed.
Life 2023, 13(5), 1134; https://doi.org/10.3390/life13051134
Received: 27 March 2023 / Revised: 2 May 2023 / Accepted: 3 May 2023 / Published: 6 May 2023
(This article belongs to the Special Issue Lyme Disease-An Incompletely Solved Puzzle)

Abstract

Objective: The diagnosis of Lyme borreliosis is based on two-tier testing using an ELISA and Western blot. About 5–10% of patients report persistent symptoms of unknown etiology after treatment, resulting in substantial difficulties in further diagnostic workup. This paper presents a study aimed at determining whether serology can differentiate between patients with persistent symptoms attributed to Lyme and other patients with Lyme borreliosis.
Methods: A retrospective cohort study included 162 samples from four subgroups: patients with persistent symptoms of Lyme (PSL), early Lyme borreliosis with erythema migrans (EM), patients tested in a general practitioner setting (GP), and healthy controls (HC). ELISA, Western blots, and multiplex assays from different manufacturers were used to determine inter-test variations in PSL and to compare reactivity against Borrelia-specific antigens among the groups.
Results: In comparing the IgG and IgM reactivity by Western blot, IgG was more often positive in the PSL group than in the GP group. The individual antigen reactivity was similar between the PSL and EM or GP groups. Inter-test agreement among the manufacturers was variable, and agreement was higher for IgG testing compared to IgM.
Conclusions: Serological testing is unable to define the subgroup of patients with persistent symptoms attributed to Lyme borreliosis. Additionally, the current two-tier testing protocol shows a large variance among different manufacturers in these patients.
_________________
**Comment**
Another study showing the obvious: Lyme testing sucks all around.
A few points:
  • If I’ve said it once, I’ve said it 1,000 times: all percentages regarding Lyme/MSIDS are always, repeat always, horrifically low.  The numbers of people suffering from persistent symptoms is far, far greater than 5-10%.  The reasons are two-fold: 1) percentages touted only count those diagnosed and treated early  2) people are typically not diagnosed early due to the faulty testing  Everything regarding Lyme/MSIDS is driven by a vortex of circular reasoning without end and nothing ever changes.
  • Now, yet another study proves testing sucks.
  • The question is, and has always been, when is something going to be done about this other than the creation of a supposed magic-bullet and lucrative Lyme “vaccine” that historically has maimed people?

For more:

The form of testing used to determine Lyme infection has been a source of heated debate from the beginning:  https://madisonarealymesupportgroup.com/2018/04/03/cdc-deliberately-avoids-direct-detection-testing-methods-for-ld/  Excerpt:

It would appear that there has been a deliberate avoidance of direct detection methods and it is believed that these efforts are to insure that the current thirty year dogma remain intact.

We have a dire need to develop rapid detection methods for a serious growing health threat which has the ability to disable its victim as described in the attached letter addressed to the previous Director of the CDC. (Please see attachment in link)

I would like to point out that employees of the U.S. Centers for Disease Control hold patents on metabolomics (Lyme tests).

CDC Employee Patent: https://www.google.com/patents/EP2805168A1?cl=en

For nearly four decades now the only FDA approved test for Lyme disease is the indirect two-tiered antibody test. Direct detection methods to identify the causative agent responsible for the disease have been avoided, criticized and shelved.

After publishing the 2013 article ‘A simple method for the detection of live Borrelia spirochetes in human blood using classical microscopy techniques’, professor Laane was invited to give a lecture at the 2014 Norvect conference in Oslo. An English patient saved the pdf, so you can still read it, via the link provided.

I was present at that conference and still remember how nervous he was. The reason was that several medical professors complained to his university. He was threatened with losing his job, if he would speak at the conference.

In fact, he did not literally speak – as you can see in the movie below – but used performing arts to show the slides of the spirochetes. Professor Laane was fired anyway and his laboratory was closed down.

It must be understood that testing has and continues to be used by ‘the powers that be’ to control the narrative.  They can virtually create a ‘pandemic’ anytime they want, and conversely deny a true pandemic.  Regarding Lyme, the narrative has been and continues to be that it is a simple nuisance either causing an immune response or is simply cured with a few weeks of doxycycline monotherapy.  Nothing could be further from the truth and reality and science continue to show this, but is simply ignored.  Go here for the CDC playbook.  Once you understand their MO, everything else makes sense.

Category:

Lyme, research, Testing